Monsanto (MON) Misses Q2 Earnings And Revenue Estimates

Monsanto Company (MON - Free Report) has carved a name for itself in the global agricultural chemicals’ industry. The company tries to enhance the yield and quality of several commercial and non-commercial agricultural crops such as cotton, soybean and corn.

Currently, MON has a Zacks Rank 3 (Hold), but that could definitely change after the release of its second-quarter fiscal 2018 (ended February 2018) results. 

We have highlighted some of the key stats from this just-revealed announcement below:

Earnings: MON reported adjusted earnings of $3.22 per share in second-quarter fiscal 2018 (on an ongoing basis), lower than the Zacks Consensus Estimate of $3.38 cents per share.

Revenue: MON posted revenues of $5,019 million in second-quarter fiscal 2018, lower than the Zacks Consensus Estimate of $5,489 million.  

Key Factors: MON perceives that improved glyphosate pricing and stronger demand for innovative crop yield enhancing solutions such as Intacta RR2 PRO soybeans will boost near-term results.

MON anticipates to successfully close Bayer AG’s (BAYRY - Free Report) buyout deal by the end second calendar quarter of 2018.

Stock Price:At the time of writing, the stock price of MON was down nearly 0.96% ($1.12) in the pre-market trade on Nasdaq. Clearly the initial reaction to the release is negative. We perceive that the company’s weaker-than-expected earnings result has primarily driven the negative sentiment.

As of Apr 5, 2018, MON’s stock closed the trading session at $116.75 per share.  

Monsanto Company Price

Disclaimer: Neither Zacks Investment Research, Inc. nor its Information Providers can guarantee the accuracy, completeness, timeliness, or correct sequencing of any of the Information on the Web ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.